(Q35084253)

6 August 2017

1 reference

title

T-cell responses of vaccinated cancer patients (English)

1 reference

6 August 2017

Pierre G Coulie

1

1 reference

PubMed ID

12633661

6 August 2017

Pierre van der Bruggen

series ordinal

2

1 reference

6 August 2017

1 April 2003

1 reference

Current Opinion in Immunology

6 August 2017

1 reference

6 August 2017

15

1 reference

6 August 2017

131-137

1 reference

6 August 2017

2

1 reference

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Estimating the precursor frequency of naive antigen-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Use of class II tetramers for identification of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Assessing CD8 T cell number and dysfunction in the presence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Kinetics of TCR use in response to repeated epitope-specific immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

Short-term kinetics of tumor antigen expression in response to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900009-8

7 January 2021

10.1016/S0952-7915(03)00009-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12633661